NORML

MARCH 7, 2019

Shanita Penny, President of the Minority Cannabis Business Association (MCBA) said , “The Ending Federal Marijuana Prohibition Act of 2019 removes a roadblock impeding criminal justice reform, patient and consumer access, research and innovation.

Legislation 258

Legislation Marijuana Policy Research and Development 258

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 111

Consumption Patients Research and Development Data 111

MMJ Recs

AUGUST 20, 2021

The use of cannabis in scientific research in the US has been at a standstill for the last five decades. The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. What does federally funded cannabis research mean for medical marijuana development?

Access 52

Access Research and Development Marijuana Chronic Pain 52

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Veriheal

OCTOBER 3, 2022

On top of recognizing the vast scope of benefits cannabis can provide, patients are saving lots of hard-earned money by swapping their pills for cannabis. People often associate pharmaceuticals with being man-made, but some pharmaceutical companies are developing medications made with natural ingredients. pharmaceuticals).

Pharmaceutical 105

Pharmaceutical Patients Research and Development Legalization 105

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JUNE 28, 2021

The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. “We are constantly seeking ways to enhance the life of chronically neurologically ill patients with our products. The first treatment will be launched in Germany in Summer 2021.

Access 105

Access Research and Development Pharmaceutical Therapy 105

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects. What is ECS?

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

AUGUST 3, 2021

Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.

Patients 105

Patients Law Research and Development Medicine 105

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Veriheal

AUGUST 21, 2023

million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.

Therapy 95

Therapy Research and Development Treatment Environment 95

MMJ Recs

OCTOBER 30, 2023

Medical marijuana (MMJ) dispensaries play a crucial role in providing patients with access to the cannabis products they need for managing various health conditions. Visiting an MMJ dispensary comes with a set of unwritten rules and etiquettes that patients should be aware of. This is a legal requirement in many states.

Dispensary 98

Dispensary Patients Strains Research and Development 98

Cannabis Law Report

JULY 6, 2021

This collaboration is intended to include research into COMP360 psilocybin therapy and other novel therapies that may be developed by COMPASS in areas of unmet need such as depression, post-traumatic stress disorder (PTSD) and anorexia.

Research and Development 76

Research and Development Clinical Trials Therapy Patients 76

NORML

APRIL 5, 2019

She also signed bills to allow medical cannabis to be administered to patients while at school, and a broader medical expansion bill that adds several new qualifying conditions and patient protections. Update : SB 34 was approved by the Senate Business, Professions and Economic Development Committee on 4/3/19. CA resident?

Legislation 210

Legislation Banking Hemp Compliance 210

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Legislation is pending, HB 350, to expand medical cannabis access. NH resident? GA resident?

Legislation 132

Legislation Clinical Trials Research and Development Access 132

The Cannigma

SEPTEMBER 21, 2021

There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel.

Patients 97

Patients Programs Sleep Retail 97

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. There have been various individual studies of the condition, but the Ehave study could be the largest patient study to date. Some people have different flashback experience. Gabe@Ehave.com.

Research and Development 81

Research and Development Conditions Data Patients 81

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. .

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 16, 2021

The group’s primary focus is to provide the necessary resources and guidance to advance a comprehensive medical cannabis package that allows professionalization, clinical research and greater access. The Council represents ACCM’s further commitment to support legislation that allows research and access.

Legislation 98

Legislation Medicine Advocacy Research and Development 98

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

MGC Pharma

FEBRUARY 21, 2018

Our Australian Health Minister, Greg Hunt, believes that the move will not only assist overseas markets, but also help grow the developing market here on Australian soil. “By Currently in Australia there is very limited patient access, firm restrictions on production and an arduous prescription process in place for medical professionals.

Research and Development 100

Research and Development Pharmaceutical Medicine Patients 100

MMJ Recs

JULY 9, 2024

Patients often struggle with symptoms that range from physical discomfort to cognitive impairment. In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

MMJ Recs

JUNE 9, 2024

West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. For many prospective medicinal marijuana patients, navigating the process of obtaining medical cannabis may be daunting.

Access 52

Access Marijuana Patients Programs 52

Puff Puff Post

DECEMBER 12, 2018

VANCOUVER — Doctors with opposing views on whether medical marijuana should be prescribed for various conditions agree on one thing: their profession is ill-prepared to deal with patients asking for a drug that lacks adequate clinical research. On the other side, Dr. .” “It’s a tough situation.

Patients 76

Patients Research and Development Conditions Chronic Pain 76

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Cannabis Law Report

FEBRUARY 5, 2022

Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP , explore the UK’s doomed Medical Cannabis (Access) Bill. For UK-based patients struggling to access much needed cannabis-based medicines, it has been difficult to be heard over the white noise of the daily news cycle. Barriers to patient access.

Access 52

Access Research and Development Medicine Patients 52

NORML

APRIL 26, 2019

At the state level, Governor Doug Burgum of North Dakota signed a package of bills into law to expand the state’s medical cannabis access program. House Bill 243, as well as Senate Bill 236, would provide registered patients with regulated access to medical cannabis via licensed providers. AL resident? AL resident?

Legislation 180

Legislation Compliance Compliance Hemp 180

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58